ReviewFrontiers in immunology2021

Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis.

XiaoQin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.